NAS:INO (USA) Also Trade In: Germany Mexico UK

Inovio Pharmaceuticals Inc $ 17 1.33 (8.49%)

Volume:
59,699,959
Avg Vol (1m):
21,798,629
Market Cap $:
2.85 Bil
Enterprise Value $:
2.58 Bil
P/E (TTM):
0.00
P/B:
14.49
Warning! GuruFocus has detected 5 Severe warning signs with INO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Inovio Pharmaceuticals Inc () from 1998 to Sep 19 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Inovio Pharmaceuticals stock (INO) PE ratio as of Sep 19 2020 is 0. More Details

Inovio Pharmaceuticals PE Ratio (TTM) Chart

EMBED

Inovio Pharmaceuticals PE Ratio (TTM) Historical Data

Total 1295
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Inovio Pharmaceuticals PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-09-190.0 2020-07-200.0
2020-09-180.0 2020-07-170.0
2020-09-170.0 2020-07-160.0
2020-09-160.0 2020-07-150.0
2020-09-150.0 2020-07-140.0
2020-09-140.0 2020-07-130.0
2020-09-110.0 2020-07-100.0
2020-09-100.0 2020-07-090.0
2020-09-090.0 2020-07-080.0
2020-09-080.0 2020-07-070.0
2020-09-070.0 2020-07-060.0
2020-09-040.0 2020-07-030.0
2020-09-030.0 2020-07-020.0
2020-09-020.0 2020-07-010.0
2020-09-010.0 2020-06-300.0
2020-08-310.0 2020-06-290.0
2020-08-280.0 2020-06-260.0
2020-08-270.0 2020-06-250.0
2020-08-260.0 2020-06-240.0
2020-08-250.0 2020-06-230.0
2020-08-240.0 2020-06-220.0
2020-08-210.0 2020-06-190.0
2020-08-200.0 2020-06-180.0
2020-08-190.0 2020-06-170.0
2020-08-180.0 2020-06-160.0
2020-08-170.0 2020-06-150.0
2020-08-140.0 2020-06-120.0
2020-08-130.0 2020-06-110.0
2020-08-120.0 2020-06-100.0
2020-08-110.0 2020-06-090.0
2020-08-100.0 2020-06-080.0
2020-08-070.0 2020-06-050.0
2020-08-060.0 2020-06-040.0
2020-08-050.0 2020-06-030.0
2020-08-040.0 2020-06-020.0
2020-08-030.0 2020-06-010.0
2020-07-310.0 2020-05-290.0
2020-07-300.0 2020-05-280.0
2020-07-290.0 2020-05-270.0
2020-07-280.0 2020-05-260.0
2020-07-270.0 2020-05-250.0
2020-07-240.0 2020-05-220.0
2020-07-230.0 2020-05-210.0
2020-07-220.0 2020-05-200.0
2020-07-210.0 2020-05-190.0

Inovio Pharmaceuticals PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325414 NAICS : 2836
Address 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.